Advertisement
UK markets closed
  • FTSE 100

    8,317.59
    -21.64 (-0.26%)
     
  • FTSE 250

    20,770.93
    +139.63 (+0.68%)
     
  • AIM

    810.02
    +5.00 (+0.62%)
     
  • GBP/EUR

    1.1741
    +0.0004 (+0.04%)
     
  • GBP/USD

    1.2740
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    53,933.83
    -373.84 (-0.69%)
     
  • CMC Crypto 200

    1,488.54
    +20.44 (+1.39%)
     
  • S&P 500

    5,304.72
    +36.88 (+0.70%)
     
  • DOW

    39,069.59
    +4.29 (+0.01%)
     
  • CRUDE OIL

    77.84
    +0.12 (+0.15%)
     
  • GOLD FUTURES

    2,336.60
    +2.10 (+0.09%)
     
  • NIKKEI 225

    38,734.63
    +88.52 (+0.23%)
     
  • HANG SENG

    18,608.94
    0.00 (0.00%)
     
  • DAX

    18,693.37
    +2.07 (+0.01%)
     
  • CAC 40

    8,094.97
    -7.36 (-0.09%)
     

Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

CHICAGO, March 14, 2024--(BUSINESS WIRE)--Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced today that Dr. Yin Ho, Veradigm Interim Chief Executive Officer and board member, Lee Westerfield, Interim Chief Financial Officer, and Will Manidis Co-Founder of ScienceIO will participate in a fireside chat at the KeyBanc Capital Markets Life Science & MedTech Investor Forum on Tuesday, March 19th, 2024 at 12:00 PM EDT.

The webcast will be available in the investor section of the company's website at investor.veradigm.com, with an archived version accessible later that same day.

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.

ADVERTISEMENT

© 2024 Veradigm Inc. and/or its affiliates. All rights reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240314344298/en/

Contacts

Investors:
Jenny Gelinas
312-506-1237
jenny.gelinas@veradigm.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@veradigm.com